Wellbutrin® (bupropion) and other Antidepressant Drugs
Cardiac birth defects, fetal or infant death
An article published in July, 2010 in The American Journal of Obstetrics and Gynecology indicates increased risks of heart and other birth defects when the drug Wellbutrin® or its equivalent Zyban® (used for smoking cessation) were taken by the mother sometime in the month before getting pregnant or within three months into the pregnancy.
Sheller, P.C. attorney wins landmark antidepressant birth defects case in 2009
Recent Paxil-related trials have drawn international attention. Attorney Jamie L. Sheller, local counsel in the Kilker matter heard in the Philadelphia court system, represented a mother who says Paxil® manufacturer GlaxoSmithKline continued to promote the drug while withholding evidence that it caused significant birth defects. Continuing to take Paxil® while pregnant after being assured it was safe, the client’s son was hospitalized and required heart surgery following birth and will require more surgery. Plaintiffs prevailed, securing a $2.5 million trial verdict in the Philadelphia Court of Common Pleas litigation. It is the first of 600 cases regarding the antidepressant Paxil® and birth defects.
GlaxoSmithKline also manufactures Wellbutrin® and Zyban®, receiving approval for treatment of depression and smoking cessation from the FDA in 1985.
Brand and generic names of the drugs that may cause heart and other birth defects:
- Wellbutrin®
- Wellbutrin XL®
- Wellbutrin SR®
- bupropion (generic)
- budepropion (generic)
- Zyban®
The cardiac birth defects being investigated include:
- Septal heart defects (hole or other leakage)
- Conotruncal heart defects
- Left outflow tract heart defects
- Right outflow heart defects
- Pulmonary valve stenosis
The attorneys of Sheller, P.C. are actively investigating the cardiac birth defects that may be related to these drugs
Nationally known for its successes representing individuals and in class action for injuries caused by defective drugs, the law firm of Sheller, P.C. is actively investigating the incidence and severity of these cases.
Contact us now
If your child or a child you know was born with any of these birth defects after the mother has taken one of these drugs immediately prior to or during the first trimester of pregnancy, contact us immediately by calling 888-883-2299 or filling out the inquiry form on this page. Protect your rights as well as your child’s health now and in the future.
Related information
“Maternal Use of bupropion and risk for congenital heart defects” July, 2010, The American Journal of Obstetrics and Gynecology.
VIDEO: “Paxil on Trial” Jamie Sheller Esq. on The American Law Journal discussing the landmark antidepressant birth defects case (2009) Click here for Attorney Sheller's profile page, video located in right column
This webpage is also accessed via these domains:
www.Wellbutrin-birthdefects.com
www.zyban-birthdefects.com
Click here to read full attorney disclaimers
